State of the Art in Artificial Intelligence and Radiomics in Hepatocellular Carcinoma
The most common liver malignancy is hepatocellular carcinoma (HCC), which is also associated with high mortality. Often HCC develops in a chronic liver disease setting, and early diagnosis as well as accurate screening of high-risk patients is crucial for appropriate and effective management of thes...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/7/1194 |
id |
doaj-3b68f61953b543f39ed07f30b64b9e90 |
---|---|
record_format |
Article |
spelling |
doaj-3b68f61953b543f39ed07f30b64b9e902021-07-23T13:37:08ZengMDPI AGDiagnostics2075-44182021-06-01111194119410.3390/diagnostics11071194State of the Art in Artificial Intelligence and Radiomics in Hepatocellular CarcinomaAnna Castaldo0Davide Raffaele De Lucia1Giuseppe Pontillo2Marco Gatti3Sirio Cocozza4Lorenzo Ugga5Renato Cuocolo6Department of Advanced Biomedical Sciences, University of Naples “Federico II”, 80131 Naples, ItalyDepartment of Advanced Biomedical Sciences, University of Naples “Federico II”, 80131 Naples, ItalyDepartment of Advanced Biomedical Sciences, University of Naples “Federico II”, 80131 Naples, ItalyRadiology Unit, Department of Surgical Sciences, University of Turin, 10124 Turin, ItalyDepartment of Advanced Biomedical Sciences, University of Naples “Federico II”, 80131 Naples, ItalyDepartment of Advanced Biomedical Sciences, University of Naples “Federico II”, 80131 Naples, ItalyDepartment of Clinical Medicine and Surgery, University of Naples “Federico II”, 80131 Naples, ItalyThe most common liver malignancy is hepatocellular carcinoma (HCC), which is also associated with high mortality. Often HCC develops in a chronic liver disease setting, and early diagnosis as well as accurate screening of high-risk patients is crucial for appropriate and effective management of these patients. While imaging characteristics of HCC are well-defined in the diagnostic phase, challenging cases still occur, and current prognostic and predictive models are limited in their accuracy. Radiomics and machine learning (ML) offer new tools to address these issues and may lead to scientific breakthroughs with the potential to impact clinical practice and improve patient outcomes. In this review, we will present an overview of these technologies in the setting of HCC imaging across different modalities and a range of applications. These include lesion segmentation, diagnosis, prognostic modeling and prediction of treatment response. Finally, limitations preventing clinical application of radiomics and ML at the present time are discussed, together with necessary future developments to bring the field forward and outside of a purely academic endeavor.https://www.mdpi.com/2075-4418/11/7/1194hepatocellular carcinomaimagingradiomicsmachine learningdeep learning |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Anna Castaldo Davide Raffaele De Lucia Giuseppe Pontillo Marco Gatti Sirio Cocozza Lorenzo Ugga Renato Cuocolo |
spellingShingle |
Anna Castaldo Davide Raffaele De Lucia Giuseppe Pontillo Marco Gatti Sirio Cocozza Lorenzo Ugga Renato Cuocolo State of the Art in Artificial Intelligence and Radiomics in Hepatocellular Carcinoma Diagnostics hepatocellular carcinoma imaging radiomics machine learning deep learning |
author_facet |
Anna Castaldo Davide Raffaele De Lucia Giuseppe Pontillo Marco Gatti Sirio Cocozza Lorenzo Ugga Renato Cuocolo |
author_sort |
Anna Castaldo |
title |
State of the Art in Artificial Intelligence and Radiomics in Hepatocellular Carcinoma |
title_short |
State of the Art in Artificial Intelligence and Radiomics in Hepatocellular Carcinoma |
title_full |
State of the Art in Artificial Intelligence and Radiomics in Hepatocellular Carcinoma |
title_fullStr |
State of the Art in Artificial Intelligence and Radiomics in Hepatocellular Carcinoma |
title_full_unstemmed |
State of the Art in Artificial Intelligence and Radiomics in Hepatocellular Carcinoma |
title_sort |
state of the art in artificial intelligence and radiomics in hepatocellular carcinoma |
publisher |
MDPI AG |
series |
Diagnostics |
issn |
2075-4418 |
publishDate |
2021-06-01 |
description |
The most common liver malignancy is hepatocellular carcinoma (HCC), which is also associated with high mortality. Often HCC develops in a chronic liver disease setting, and early diagnosis as well as accurate screening of high-risk patients is crucial for appropriate and effective management of these patients. While imaging characteristics of HCC are well-defined in the diagnostic phase, challenging cases still occur, and current prognostic and predictive models are limited in their accuracy. Radiomics and machine learning (ML) offer new tools to address these issues and may lead to scientific breakthroughs with the potential to impact clinical practice and improve patient outcomes. In this review, we will present an overview of these technologies in the setting of HCC imaging across different modalities and a range of applications. These include lesion segmentation, diagnosis, prognostic modeling and prediction of treatment response. Finally, limitations preventing clinical application of radiomics and ML at the present time are discussed, together with necessary future developments to bring the field forward and outside of a purely academic endeavor. |
topic |
hepatocellular carcinoma imaging radiomics machine learning deep learning |
url |
https://www.mdpi.com/2075-4418/11/7/1194 |
work_keys_str_mv |
AT annacastaldo stateoftheartinartificialintelligenceandradiomicsinhepatocellularcarcinoma AT davideraffaeledelucia stateoftheartinartificialintelligenceandradiomicsinhepatocellularcarcinoma AT giuseppepontillo stateoftheartinartificialintelligenceandradiomicsinhepatocellularcarcinoma AT marcogatti stateoftheartinartificialintelligenceandradiomicsinhepatocellularcarcinoma AT siriococozza stateoftheartinartificialintelligenceandradiomicsinhepatocellularcarcinoma AT lorenzougga stateoftheartinartificialintelligenceandradiomicsinhepatocellularcarcinoma AT renatocuocolo stateoftheartinartificialintelligenceandradiomicsinhepatocellularcarcinoma |
_version_ |
1721288765168680960 |